- Polypeptides refer to a class of compounds formed by amino acids linked by peptide bonds.
- Peptide market analysis indicates that peptide drugs are mainly used in the fields of chronic diseases, tumors and rare diseases.
- With the improvement of polypeptide production technology in China, the production of polypeptide has also been greatly improved.
- At present, there are many enterprises involved in peptide production in China, but most of them have small production capacity and production scale, low product grade and relatively scattered industrial pattern.
Polypeptides refer to a class of compounds formed by amino acids linked by peptide bonds.
About 30% of the peptide drugs in clinical trials are conjugates. There are 128 peptide drugs entering clinical research. In 2019, the global demand for peptide industry will be about 16.8 billion tons. The following is the analysis of peptide market.
Polypeptides are a class of compounds formed by multiple amino acids linked by peptide bonds. They are usually composed of 10-100 amino acid molecules. Their connection mode is the same as that of proteins, and the relative molecular weight is less than 10000.
Peptide industry analysis points out that polypeptides are ubiquitous in organisms, and tens of thousands of polypeptides have been found in organisms so far. They widely participate in and regulate the functional activities of various systems, organs, tissues and cells in the body, and play an important role in life activities.
Peptide market analysis indicates that peptide drugs are mainly used in the fields of chronic diseases, tumors and rare diseases.
With the expiration of patents of several polypeptide varieties, polypeptide generic drugs will usher in development opportunities.
Meanwhile, upstream peptide API manufacturers will also benefit from the growth of generic drug market. The global market of peptide drugs has exceeded US $20 billion, accounting for about 2% of the total market share of medical drugs, maintaining a growth rate of about 10%.
Compared with the international market, the peptide industry market in China is still in a period of rapid growth. On the one hand, due to the immature peptide application market in China, there is still a huge room for growth in important application fields such as peptide drugs, nutritional food and cosmetics;
on the other hand, the prevalence of tumor and chronic diseases in China has increased due to the aggravation of aging, changes in living habits and environmental degradation, which aggravates the demand for peptide drugs.
With the improvement of polypeptide production technology in China, the production of polypeptide has also been greatly improved.
Peptide can be used in many fields such as medicine, food, cosmetics and so on. In 2019, the output of polypeptide raw materials in China will be about 171.3 tons.
The demand for peptide industry in China is also gradually increasing. In 2019, the demand of peptide industry in China will be about 168.2 tons.
More than 100 polypeptide drugs have entered clinical trials in China, and more than 400 polypeptide drugs are in the preclinical research stage. Peptide market analysis shows that among the 128 candidate multi-component drugs under clinical trials, 40 have entered phase 1 clinical trials, 74 have entered phase I / II or phase II clinical trials, and 14 have entered phase II / III or phase III clinical trials;
peptide drugs in phase I and II clinical research stage play a leading role in the treatment of metabolic diseases and tumors; Peptide drugs in the phase III clinical research are mostly used in the treatment of cancer and infectious diseases, among which anti-tumor peptide drugs account for more than 40%.
At present, there are many enterprises involved in peptide production in China, but most of them have small production capacity and production scale, low product grade and relatively scattered industrial pattern.
In 2020, with the further development of polypeptide industry chain in China, the localization degree of raw materials will be further improved, and the number of suppliers will be gradually increased, and the selection range of raw materials will be further expanded, which is conducive to the long-term and stable development of polypeptide enterprises.
Generally speaking, peptide therapy in China has a bright future, but the therapy is not perfect. The existence of peptidase leads to the short half-life of peptide hormones, which has a negative impact on drug development and treatment. Another technical bottleneck of peptide drugs is the low oral utilization rate.
In order to overcome the above technical problems, a new peptide synthesis strategy came into being. Researchers can reduce the injection frequency of peptide drugs and improve the stability and other physical properties by adjusting the pharmacokinetic characteristics, modifying the amino acid skeleton, adding unnatural amino acids, conjugating groups with extended half-life, and improving solubility.
For sale, buy peptides, purchase peptides, and buy peptides online, you can find the Chinese peptide company:
Shengnuo Biotechnology is a high-tech China polypeptide manufacturers,who has over 19 years experience for the biotechnology .Our Products involve peptide raw materials,polypeptide drug.
Our 0 defect has passed the FDA certification, and has become the first-class professional polypeptide drug and product development and large-scale production and export industry in China .
Our service scope：peptide synthesis、peptide hormones、peptide medicine、beauty peptide、peptide medicine product、peptide technology transfer、peptide technology service、peptide large-scale production、export of peptide
Thymopentin for Injection、 Thymalfasin for Injection 、 Bivalirudin 、Bulk Drug、 Liraglutide ……
How many companies are there in peptide api manufacturer in china? The peptide api market is very promising, and the world is encouraging the development of peptide business. There is a peptide api list on the website Biofda.com, which contains various specifications of peptide APIs for customers to choose from. Shengnuo Technology is a peptide api manufacturer located in Chengdu, a city in southwest China. Not only peptide APIs, but also carnosine custom suppliers and cosmetic peptide suppliers
are many peptide apis manufacture in China, but they are all small-scale companies. The China peptide company such as Sinotech is a leading company in China and has a very high position.
As a Chinese peptide company, Sinotech has been working silently, hoping to become a top peptide company in the world. There are many countries producing peptides in the world, such as bulk drug substance in India, gmp custom peptide in uk, and peptide production in usa. So what is polypeptide? What kind of peptide synthesis supplier should you choose? Follow our website: www.biofda.com, here will tell you the answer.